Economic evaluation of sublingual vs subcutaneous allergen immunotherapy
Authors:
- Jitka PokladnikovaJPJitka Pokladnikova
- Irena KrcmovaIKIrena Krcmova
- Jiri VlcekJVJiri Vlcek
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 100 (5) , 482-489
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Greater risk of incident asthma cases in adults with Allergic Rhinitis and Effect of Allergen Immunotherapy: A Retrospective Cohort StudyRespiratory Research, 2005
- Health-Economic Analyses of subcutaneous Specific Immunotherapy for grass pollen and mite allergyAllergologia et Immunopathologia, 2005
- Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis*Allergy, 2004
- The Economic Burden of Allergic RhinitisPharmacoEconomics, 2004
- Long‐lasting clinical efficacy of allergen specific immunotherapyAllergy, 2002
- Allergic Rhinitis and Its Impact on AsthmaJournal of Allergy and Clinical Immunology, 2001
- Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective studyClinical & Experimental Allergy, 2001
- Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trialJournal of Allergy and Clinical Immunology, 2001
- Economic Evaluation of Specific Immunotherapy Versus Symptomatic Treatment of Allergic Rhinitis in GermanyPharmacoEconomics, 2000
- Allergen immunotherapy: therapeutic vaccines for allergic diseasesAllergy, 1998